|
1
|
Improving selection criteria for lung cancer screening. The potential role of emphysema.
|
Am J Respir Crit Care Med
|
2015
|
1.55
|
|
2
|
A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
|
J Clin Oncol
|
2013
|
1.47
|
|
3
|
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.
|
J Immunol
|
2012
|
1.30
|
|
4
|
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.
|
Cancer Res
|
2004
|
1.19
|
|
5
|
Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens.
|
BMC Mol Biol
|
2008
|
0.95
|
|
6
|
Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells.
|
Int J Cancer
|
2008
|
0.90
|
|
7
|
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.
|
PLoS One
|
2012
|
0.88
|
|
8
|
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|